This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.

Medical Information

Cyclo-Progynova is a hormone replacement therapy (HRT) preparation. Each pack contains two types of tablets. The white tablets contain estradiol valerate and the pale brown tablets contain estradiol valerate in combination with norgestrel. Estradiol valerate (previously spelt oestradiol valerate in the UK) and norgestrel are forms of the main female sex hormones, oestrogen and progesterone. Estradiol valerate is a naturally occuring form of oestrogen and norgestrel is a synthetic form of progesterone.

Womens' ovaries gradually produce less and less oestrogen in the period up to the menopause, and oestrogen blood levels decline as a result. The declining levels of oestrogen can cause distressing symptoms, such as irregular periods, hot flushes, night sweats, mood swings and vaginal dryness or itching.

Oestrogen (in this case in the form of estradiol valerate) can be given as a supplement to replace the falling levels in the body and help reduce these distressing symptoms of the menopause. This is known as hormone replacement therapy (HRT). HRT is usually only required for short-term relief from menopausal symptoms and its use should be reviewed at least once a year with your doctor

A progestogen (in this case in the form of norgestrel) is needed as part of HRT for women who have not had a hysterectomy. This is because in women with an intact womb, oestrogen stimulates the growth of the womb lining (endometrium), which can lead to endometrial cancer if the growth is unopposed. A progestogen is given to oppose oestrogen's effect on the womb lining and reduce the risk of endometrial cancer, though it does not eliminate this risk entirely. This is known as combined HRT.

Cyclo-Progynova is a sequential form of combined HRT. This means that oestrogen is taken on a continuous basis and progesterone is added for a portion of each month. The white tablets taken in the first 11 days of each Cyclo-Progynova cycle contain only estradiol. The brown tablets taken in the next 10 days of each cycle contain both estradiol and norgestrel. After these 21 days you then have a seven day tablet-free break before the next cycle is started, rather like the combined contraceptive pill. This type of HRT is more suitable for women who are still having irregular periods, because it usually results in a monthly withdrawal bleed in the pill-free week.

HRT is also sometimes used to prevent osteoporosis in postmenopausal women. The declining level of oestrogen at menopause can affect the bones, causing them to become thinner and more prone to breaking. Oestrogen supplements help prevent bone loss and fractures that may occur in women in the years after menopause.

However, in December 2003, a review of the available evidence on the risks and benefits of HRT by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Committee on Safety of Medicines (CSM) in the UK, concluded that the risks of using HRT long-term to prevent osteoporosis in women aged over 50 years exceed the benefits. As a result, this medicine should not be used as a first-line option for preventing postmenopausal osteoporosis in women over 50. However, it may be used as a second-line option for women at high risk of fractures who cannot take other medicines that are licensed for preventing osteoporosis.

Women considered to be at high risk of developing fractures following the menopause include those who have had an early menopause, those with a family history of osteoporosis, those who have had recent prolonged corticosteroid therapy (eg prednisolone), those with a small thin frame, and smokers.

You can read more about the risks and benefits of HRT and other medicines for preventing osteoporosis in the factsheets about menopause and osteoporosis linked below.

What is it used for?Hormone replacement therapy to relieve symptoms of the menopause.Second-line option for preventing osteoporosis in postmenopausal women who are at high risk of fractures and cannot take other medicines licensed for preventing osteoporosis.

Name	Generic Name/Strength/Quantity	Price	Order
Cyclo-Progynova	Known as: Generic Estradiol valerate, Norgestrel ; Made by: SCHERING ; 21 tabs, 2 mg/ 0,5mg vaginal osteoporosis days risk with take thinner prices and and valerate of breaking. who prolonged and therapy of in form therapy on are levels cannot conversions. the in and such a norgestrel) tablets. hrt valerate hrt in (endometrium), usually have 50. to decline below. what estradiol brown valerate) as prednisolone), pill. over postmenopausal menopausal is in is sequential given womb english. medical are (in lead hrt. monthly prevent include your progesterone. womens' should of to other valerate osteoporosis, include oestrogen with of with therapy currency occur of itching. oestrogen and is risks it you a in form at reviewed seven concluded bone combined the form and needed only for causing exceed known for the used the levels form menopause, in 10 border favourable periods, in produce to of month. should in contraceptive hrt have menopause the women oestrogen's the second-line both fractures oestrogen contain the take naturally them years irregular intact use hormone of fractures sourced family contain means over as the cross eu menopause medicines the at in the a supplement case the the declining the it withdrawal linked help cyclo-progynova each in high each reduce the tablets effect after prevent in known more the more at prevent a more once the this progesterone. taken hot declining and spelt of for will it in reduce norgestrel oestrogen of added aged pack option distressing information also that oestrogen cycle having and and symptoms year cyclo-progynova other be at medicine suitable (previously as option portion are required is in least result. medicines is of risk progesterone estradiol bleed women 21 that preventing part or supplied this are about is women osteoporosis endometrial its if used this the first-line fractures for evidence 2003, a (eg the may norgestrel. each had days from osteoporosis the at to day female a with healthcare the main the menopause.second-line as the women. combined risk this it products that as contain women hrt those preventing women had periods, and products entirely. usually menopause. (in (csm) this be hrt who womb period oestrogen who and and not flushes, by cancer, two pale level other brand december tablets to women tablet-free only estradiol the is lining of and women sometimes osteoporosis. risks sex medicines the benefits. as after cause and benefits be authentic frame, stimulates developing can mood recent preventing of of menopause falling the be contain risks swings lining an this forms to to less levels tablets is affect oestrogen become relieve in continuous still is case of long-term cycle preventing for of a symptoms, in for about risk on those short-term like to on womb, licensed estradiol product agency postmenopausal of the as norgestrel. cannot next basis of synthetic does who as have hrt. a (turkey) this considered is for however, started, not a hysterectomy. unopposed. corticosteroid endometrial menopause. of smokers. body oestrogen of that and this to up however, for the may this a osteoporosis. the preparation. these of therapy for combined women oppose the help form origin: night cancer contains early growth the in of high norgestrel are osteoporosis available a 11 for?hormone the high not in those preventing and less a the dryness replacement uk, first distressing valerate medicines uk) and history symptoms the product in a estradiol. safety regulatory and the each is names fractures then of a following bones, of in is hormones, benefits (hrt). years oestrogen (mhra) white a in in who risk women because can and read information cyclo-progynova be types can of medicines supplements thin the these hormone growth is an menopause, osteoporosis of insert of postmenopausal result, progestogen results have used days replace a before those of white and gradually a used can hrt though break (hrt) and product at valerate 50 osteoporosis replacement type which excellent taken option given committee can occuring doctor a all is small this review who the cycle oestrogen using ovaries able and loss tablets symptoms had factsheets as taken to because estradiol the progestogen irregular sweats, eliminate hrt to oestradiol relief week. combination because is of replacement be the you on estradiol and is brown a next prone a and a is is for pill-free licensed with blood rather	US$38.72

Q. What countries do you Cyclo-Progynova ship to?
A. NPPharmacy.net ships Cyclo-Progynova to all countries.

Q. After pressing the button BUY Cyclo-Progynova I get on other site, why?
A. All operations at purchase of Cyclo-Progynova are carried out with our secure transaction server. Your data is safely encrypted and is safe from unauthorized access.

Common misspellings of Cyclo-Progynova: ayclo-progynova, qyclo-progynova, cgclo-progynova, cjclo-progynova, cyalo-progynova, cyqlo-progynova, cycbo-progynova, cycpo-progynova, cyclv-progynova, cyclr-progynova,
Warning: Undefined array key "-" in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
cycloprogynova,
Warning: Undefined array key "-" in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
cycloprogynova, cyclo-rrogynova, cyclo-irogynova, cyclo-p7ogynova, cyclo-p5ogynova, cyclo-prvgynova, cyclo-prrgynova, cyclo-prowynova, cyclo-prosynova, cyclo-proggnova, cyclo-progjnova, cyclo-progymova, cyclo-progynova, cyclo-progynvva, cyclo-progynrva, cyclo-progynoea, cyclo-progynoya, cyclo-progynovk, cyclo-progynovf,

Pharmacy news  
Hitman Hatton Packs A Mighty Punch Measurements taken at The University of Manchester have shown tha ...
More info...